Yongin-si, South Korea

Sungyoo Cho


Average Co-Inventor Count = 9.6

ph-index = 2

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2023-2025

Loading Chart...
4 patents (USPTO):

Title: The Innovative Contributions of Sungyoo Cho

Introduction

Sungyoo Cho is a prominent inventor based in Yongin-si, South Korea. He has made significant contributions to the field of biotechnology, particularly in cancer treatment and cell therapy. With a total of four patents to his name, Cho's work is paving the way for advancements in medical science.

Latest Patents

Cho's latest patents include an innovative anti-HER2 antibody or antigen-binding fragment thereof, which is designed for the prevention or treatment of cancer. This novel antibody specifically targets HER2, a protein that is highly expressed in certain cancer cells, including breast and gastric cancer. The antibody binds to a unique epitope, differentiating it from existing treatments like trastuzumab. Another significant patent involves a method for culturing cord blood-derived natural killer cells using transformed T cells. This method enhances the proliferation and production of natural killer cells from a minimal amount of seed cells, improving their cytotoxicity and making them valuable for cell therapy applications.

Career Highlights

Sungyoo Cho is currently associated with Gc Cell Corporation, where he continues to innovate and develop groundbreaking therapies. His work has garnered attention in the scientific community, contributing to advancements in cancer treatment and cellular therapies.

Collaborations

Cho collaborates with notable colleagues, including Jong Seo Lee and Kyu Tae Kim, who share his vision for advancing medical science through innovative research and development.

Conclusion

Sungyoo Cho's contributions to biotechnology and cancer treatment exemplify the impact of innovative thinking in the medical field. His patents reflect a commitment to improving patient outcomes and advancing therapeutic options.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…